Patents by Inventor David J. Ledden

David J. Ledden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7499154
    Abstract: A readhead for illuminating a sample carrier and receiving light from the sample carrier, including a housing for receiving a sample carrier, an array of light sources mounted within the housing in a fixed position relative to the sample carrier, and including first and second light-emitting diodes for emitting substantially monochromatic light of a two different wavelengths, a light guide mounted in the housing between the light-emitting diodes and the sample carrier, and a light detector coupled to receive light from the sample carrier. The readhead also includes a light source for directing excitation light of a predetermined wavelength to the sample carrier, and a light filter positioned between the sample carrier and the light detector and adapted to prevent passage therethrough of the excitation light. The readhead allows both fluorescence spectroscopy and reflectance spectroscopy to be conducted on the sample carrier.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: March 3, 2009
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Nicholas T. Stock, Gary D. Ross, David J. Ledden
  • Patent number: 6093546
    Abstract: The invention relates to a process for making a test element, such as an analytical test element. Compositions of matter, such as analyte specific receptors, are treated to carry a charge. These are then applied to test carriers treated to carry a charge opposite that of the composition of matter. Interaction of charge fixes the composition of matter to the test element.
    Type: Grant
    Filed: September 3, 1992
    Date of Patent: July 25, 2000
    Assignee: Roche Diagnostics
    Inventors: David J. Ledden, David R. Moorman, Michael J. Kinch, Harvey B. Buck
  • Patent number: 5492813
    Abstract: Muteins of enzyme acceptor polypeptide fragments of .beta.-galactosidase are provided which exhibit substantially increased kinetic complementation activity with no significant loss in stability. A preferred enzyme acceptor fragment has an amino acid other than cysteine located at position 500 of the natural sequence. An especially preferred substitution is serine or valine. Other preferred muteins have an amino acid other than methionine located at position 443, with leucine being especially preferred, or an amino acid other than cysteine at position 76, with leucine being an especially preferred substitution. Also provided are methods for producing the novel muteins, reagent compositions comprising the novel muteins, and immunoassay methods for determining an analyte in which the novel mutein recombines with an enzyme donor polypeptide fragment to form enzymatically active .beta.-galactosidase.
    Type: Grant
    Filed: November 1, 1993
    Date of Patent: February 20, 1996
    Assignee: Boehringer Mannheim Corporation
    Inventors: Scott J. Eisenbeis, Sophie J. Boguslawski, Mark Krevolin, David J. Ledden
  • Patent number: 5464747
    Abstract: A mutein of an enzyme acceptor polypeptide fragment of .beta.-galactosidase which is resistant to oxidation is provided. The enzyme acceptor fragment has an amino acid other than cysteine located at position 602 of the natural sequence. An especially preferred substitution is serine. Also provided are a method for producing the novel mutein, a reagent composition comprising the novel mutein, and an immunoassay method for determining an analyte in which the novel mutein recombines with an enzyme donor polypeptide fragment to form enzymatically active .beta.-galactosidase.
    Type: Grant
    Filed: October 29, 1993
    Date of Patent: November 7, 1995
    Assignee: Boehringer Mannheim Corporation
    Inventors: Scott J. Eisenbeis, Mark Krevolin, Christopher P. Bryant, Sophie J. Boguslawski, David J. Ledden, Scott Clark
  • Patent number: 5356782
    Abstract: The invention is an apparatus useful in carrying out an analytical assay. The apparatus has a positive and negative control, as well as a site for determining the presence, amount, or lack of an analyte in a sample.
    Type: Grant
    Filed: September 3, 1992
    Date of Patent: October 18, 1994
    Assignee: Boehringer Mannheim Corporation
    Inventors: David R. Moorman, David J. Ledden, David D. Webster, Brian A. Heald
  • Patent number: 4810635
    Abstract: A specific binding assay, e.g., immunoassay, method and reagent system wherein a structural analog of the label portion of the labeled reagent is included in the reaction mixture to interact with potentially interfering substances in the test sample. The label analog is selected or designed to be substantially inactive in the assay detection system. The invention improves the precision of the assays, particularly homogeneous immunoassays, by significantly reducing or eliminating the variable interaction, e.g., binding, of the labeled reagent by interfering substances in the test sample.
    Type: Grant
    Filed: April 16, 1986
    Date of Patent: March 7, 1989
    Assignee: Miles Inc.
    Inventors: David J. Ledden, Dwight E. Schroedter